Effect of Acute Physical Exercise on Memory (SPEMO)

December 17, 2020 updated by: Igloi Kinga, University of Geneva, Switzerland

An increasing amount of studies show the beneficial effect of regular exercise on cognitive and brain functions and especially in the memory domain. Yet little is known of what happens within an acute bout of exercise and whether it would also yield cognitive effects. The literature clearly shows that molecules such as brain derived neurotrophic factor (BDNF) and endocannabinoids (mainly anandamide, AEA) are heavily involved in neural plasticity mechanisms and increase when we exercise hinting at possible mechanisms underlying memory improvement after exercise.

This protocol assesses the effects of acute exercise on associative and motor sequence memory, their underlying neural activations (measured using fMRI) and blood biomarkers (BDNF and AEA). A related aim is to assess the effect of exercise intensity, therefore three exercising conditions (rest, moderate intensity and high intensity) were included. Finally, a 3-month delayed retest visit is also realized to assess effects of acute exercise on long-term memory consolidation.

Study Overview

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 38 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Male
  • Right-handed,
  • Exercising regularly (at least twice per week).
  • VO2max comprised between 40ml/kg/min and 65ml/kg/min.

Exclusion Criteria:

- Psychiatric and neurological history

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Rest
Participants rest quietly for 30 minutes, sitting on a chair. They may read magazines not involving motion-related elements
EXPERIMENTAL: Moderate intensity exercise
Participants cycle on a cycle ergometer during 30 minutes at 65% of their maximal cardiac frequency
EXPERIMENTAL: High intensity exercise
Participants cycle on a cycle ergometer during 15 minutes at 75% of their maximal cardiac frequency. This session also includes 3 minutes of warm-up and three minutes of cool down at 50% of their maximal cardiac frequency

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cognitive measures - performance
Time Frame: Till the end of the study for each participant, i.e.3 months (long time retest)
we measure performance during cognitive tasks. Performance is measured as percentage of correct trials, with higher percentages corresponding to better performance - measured in percentages.
Till the end of the study for each participant, i.e.3 months (long time retest)
cognitive measures - reaction times
Time Frame: Till the end of the study for each participant, i.e.3 months (long time retest)
we measure reaction times during cognitive tasks. For reaction times, lower measures correspond to faster response times and therefore to better outcome - measured in milliseconds.
Till the end of the study for each participant, i.e.3 months (long time retest)
BDNF levels
Time Frame: up to 1 hour
we measure BDNF levels before and after physical exercise and rest, measured in ng/mL of serum.
up to 1 hour
endocannabinoid levels
Time Frame: up to 1 hour
we measure endocannabinoid levels before and after physical exercise and rest, measured in ng/mL of plasma.
up to 1 hour
brain activations
Time Frame: up to 1 hour
we measure brain activations using fMRI during cognitive tasks
up to 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 9, 2015

Primary Completion (ACTUAL)

July 27, 2016

Study Completion (ACTUAL)

July 27, 2016

Study Registration Dates

First Submitted

December 11, 2020

First Submitted That Met QC Criteria

December 17, 2020

First Posted (ACTUAL)

December 23, 2020

Study Record Updates

Last Update Posted (ACTUAL)

December 23, 2020

Last Update Submitted That Met QC Criteria

December 17, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • PB_2017-00360

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Physical Exercise

Clinical Trials on rest

Subscribe